Roche and Ionis Enter into Eye Disease Collaboration
By Michelle Liu
Pharma Deals Review: Vol 2018 Issue 10 (Table of Contents)
Published: 27 Oct-2018
DOI: 10.3833/pdr.v2018.i10.2366 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Following the discontinuation of its own geographic atrophy drug, lampalizumab, Roche is jumping back on to the bandwagon with a collaboration with Ionis Pharmaceuticals to develop IONIS-FB-LRx for the treatment of complement-mediated diseases, including age-related macular degeneration (AMD)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS